These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32411577)

  • 1. Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
    Endo T; Toyoshima S; Hayama K; Tagui M; Niwa Y; Ito M; Terui T; Okayama Y
    Asia Pac Allergy; 2020 Apr; 10(2):e12. PubMed ID: 32411577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
    Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
    J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
    Jörg L; Pecaric-Petkovic T; Reichenbach S; Coslovsky M; Stalder O; Pichler W; Hausmann O
    Clin Exp Allergy; 2018 Feb; 48(2):196-204. PubMed ID: 29164723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
    Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
    Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
    Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
    Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
    Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
    Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
    Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
    J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
    Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
    J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher House Dust Mite-Specific IgE Levels among Chronic Spontaneous Urticaria Patients May Implicate Higher Basophil Reactivity.
    Liang G; Zhou J; Jiang L; Wang W; Wu Q; Gao C; Liu W; Li S; Feng S; Song Z
    Int Arch Allergy Immunol; 2023; 184(11):1126-1134. PubMed ID: 37604140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.
    Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
    Allergy; 2017 Dec; 72(12):1904-1911. PubMed ID: 28585360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.
    Joerg L; Mueller-Wirth N; Kammermann K; Stalder O; Pichler W; Hausmann O
    Eur Ann Allergy Clin Immunol; 2024 Nov; 56(6):271-280. PubMed ID: 38088172
    [No Abstract]   [Full Text] [Related]  

  • 15. IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.
    Giménez-Arnau AM; Ribas-Llauradó C; Mohammad-Porras N; Deza G; Pujol RM; Gimeno R
    Clin Transl Allergy; 2022 Feb; 12(2):e12117. PubMed ID: 35126995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
    Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
    Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic urticaria sera increase basophil CD203c expression.
    Yasnowsky KM; Dreskin SC; Efaw B; Schoen D; Vedanthan PK; Alam R; Harbeck RJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1430-4. PubMed ID: 16751009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis.
    Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C
    Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study.
    Chen Q; Luo J; Yang X; Chen W; Liu W; Song Z
    Int Arch Allergy Immunol; 2024; 185(2):190-195. PubMed ID: 37952519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil activation test in children with autoimmune chronic spontaneous urticaria: Is it ready for clinical practice?
    D'Auria E; De Amici M; Licari A; Caimmi S; Mantegazza C; Zuccotti G; Marseglia G
    Immunobiology; 2019 Jan; 224(1):30-33. PubMed ID: 30466958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.